Federal Register / Vol. 74, No. 49 / Monday, March 16, 2009 / Notices 11089 

Avenue, NW, Washington, DC 20230, in 

Room 4830. The seminar will present 

climate data, services, and programs 

available from the U.S. Department of 

Commerce for U.S. companies coming 

to terms with climate variability. The 

agenda will feature strategies for 

sustainability, competitiveness, and 

networking for the business community. 

DATES: The meeting will begin at 8:30 

a.m. on Wednesday, April 1, 2009, 

recess at 3:00 p.m. 

ADDRESSES: Department of Commerce, 

14th and Constitution NW, Washington 

DC 20230, Room 4830. 

FOR FURTHER INFORMATION CONTACT: To 

register, please email your name, 

company name, contact information 

including email and phone number to: 

April1.Conference@mail.doc.gov. For 

further information, phone Ellen Bohon, 

Office of Energy and Environmental 

Technologies Industries (OEEI), 

International Trade Administration, 

U.S. Department of Commerce at (202) 

482–0359. 

SUPPLEMENTARY INFORMATION:

Special Accommodations 

This meeting is physically accessible 

to people with disabilities. Requests for 

sign language interpretation or other 

auxiliary aids should be directed to 

(202) 482–0359. 

Dated: March 10, 2009. 

Captain Todd Stiles, 

Executive Director, Office of the Deputy 

Under Secretary, National Oceanic and 

Atmospheric Administration. 

[FR Doc. E9–5640 Filed 3–13–09; 8:45 am] 

BILLING CODE 3510–12–S 

CORPORATION FOR NATIONAL AND 

COMMUNITY SERVICE 

Information Collection; Emergency 

Submission for OMB Review, 

Comment Request 

AGENCY: Corporation for National and 

Community Service. 

ACTION: Notice. 

SUMMARY: The Corporation for National 

and Community Service (hereinafter the 

‘‘Corporation’’), has submitted an 

emergency public information 

collection request (ICR) entitled 

AmeriCorps VISTA Recovery Act 

Progress Report Supplement to the 

Office of Management and Budget 

(OMB) for review and approval within 

seven days of submission. This action is 

being implemented in accordance with 

OMB guidance and the Paperwork 

Reduction Act of 1995, Public Law 104– 

13, (44 U.S.C. Chapter 35). A copy of 

this ICR, with applicable supporting 

documentation may be obtained by 

contacting the Corporation for National 

Service, AmeriCorps VISTA, Craig 

Kinnear, Program Analyst, (202) 606– 

6708, or by e-mail at ckinnear@cns.gov. 

Individuals who use a 

telecommunications device for the deaf 

(TTY–TDD) may call (202) 565–2799 

between 8:30 a.m. and 5 p.m. Eastern 

Time, Monday through Friday. 

ADDRESSES: You may submit comments, 

identified by the title of the information 

collection activity, to (1) Corporation for 

National and Community Service, and 

(2) the Office of Information and 

Regulatory Affairs. Please send 

comments to: 

(1) Corporation for National and 

Community Service, Attn: Craig 

Kinnear, Program Analyst, AmeriCorps 

VISTA by any of the following two 

methods within 30 days from the date 

of publication in this Federal Register: 

(a) By fax to: (202) 606–3475 

Attention: Craig Kinnear, Program 

Analyst, AmeriCorps VISTA; and 

(b) Electronically by e-mail to 

ckinnear@cns.gov. and 

(2) Office of Information and 

Regulatory Affairs, Attn: Ms. Sharon 

Mar, OMB Desk Officer for the 

Corporation for National and 

Community Service, by any of the 

following two methods within 30 days 

from the date of publication in this 

Federal Register: 

(a) By fax to: (202) 395–6974, 

Attention: Ms. Sharon Mar, OMBH Desk 

Officer for the Corporation for National 

and Community Service; and 

(b) Electronically by e-mail to 

smar@omb.eop.gov. 

SUPPLEMENTARY INFORMATION: The OMB 

is particularly interested in comments 

which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the Corporation, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Propose ways to enhance the 

quality, utility and clarity of the 

information to be collected; and, 

• Propose ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

through the use of appropriate 

automated, electronic, mechanical, or 

other technological collection 

techniques or other forms of information 

technology (e.g., permitting electronic 

submissions of responses). 

Current Action 

The Corporation seeks to enhance 

data elements collected via these 

information collection tools. 

Type of Review: New. 

Agency: Corporation for National and 

Community Service. 

Title: VISTA Recovery Act Progress 

Report Supplement. 

OMB Number: New. 

Agency Number: None. 

Affected Public: AmeriCorps*VISTA 

sponsoring organizations (includes 

nonprofit organizations and state, local 

and tribal agencies). 

Total Respondents: 950. 

Frequency: Quarterly. 

Average Time per Response: 1 hour. 

Estimated Total Burden Hours: 3,800. 

Total Burden Cost (capital/startup): 

None. 

Total Burden Cost (operating/ 

maintenance): None. 

Dated: March 11, 2009. 

Paul Davis, 

Acting Director, AmeriCorps*VISTA. 

[FR Doc. E9–5669 Filed 3–13–09; 8:45 am] 

BILLING CODE 6050–$$–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Notice of Continuation and Expansion 

of a Disease Management 

Demonstration Project for TRICARE 

Standard Beneficiaries 

AGENCY: Department of Defense. 

ACTION: Notice of demonstration project. 

SUMMARY: This notice is to advise 

interested parties of the continuation 

and expansion of a Military Health 

System (MHS) demonstration project 

entitled ‘‘Disease Management 

Demonstration Project for TRICARE 

Standard Beneficiaries’’. The original 

demonstration notice was published on 

June 13, 2007 (72 FR 32628–32629) and 

described a demonstration project to 

provide disease management (DM) 

services to TRICARE Standard 

beneficiaries in addition to the 

TRICARE Prime beneficiaries who were 

already entitled to such services. 

TRICARE began the demonstration 

project in March 2007 for Standard 

beneficiaries and this demonstration 

project has enabled the MHS to provide 

uniform policies and practices on 

disease and chronic care management 

throughout the TRICARE network. 

Additionally, the demonstration has 

helped determine the effectiveness of 

DM programs in improving the health 

status of beneficiaries with targeted 

11090 Federal Register / Vol. 74, No. 49 / Monday, March 16, 2009 / Notices 

chronic diseases or conditions, and any 

associated cost savings. The TRICARE 

Management Activity (TMA) chose a 

phased approach to determine the 

efficacy and cost effectiveness of its 

disease management demonstration, 

beginning with beneficiaries identified 

with the disease states of asthma, 

congestive heart failure, and diabetes. 

TMA now intends to expand the disease 

management services to TRICARE 

Standard beneficiaries with the 

additional disease states of cancer, 

Chronic Obstructive Pulmonary Disease 

(COPD), and anxiety and depression 

disorders as well as continue the 

original disease states of asthma, 

congestive heart failure, and diabetes. 

This expansion and continuation of the 

DM demonstration project will be 

conducted under the authority provided 

in 10 U.S.C. 1092. 

DATES: The expansion of the 

demonstration will be effective April 1, 

2009 and will continue for a period of 

2 years until March 31, 2011. The terms 

and conditions of the original 

demonstration notice will continue. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Barry Cohen, Director of Healthcare 

Operations—TRICARE Management 

Activity, 5111 Leesburg Pike, Suite 810, 

Falls Church, VA 22041–3206; 

telephone (703) 681–4029. 

SUPPLEMENTARY INFORMATION: 

A. Background 

For additional information on the 

TRICARE demonstration project for DM, 

please see 72 FR 32628–32629. The 

demonstration notice focused on 

explaining the differences between the 

DM benefits available to TRICARE 

Standard and TRICARE Prime 

beneficiaries and the manner in which 

DM services had been provided prior to 

the demonstration. The prior notice 

explained that for purposes of the 

demonstration, the Department of 

Defense (DoD) would waive, for these 

DM services provided to Standard 

beneficiaries, the provisions of 10 U.S.C. 

1079(a)(13) and 32 CFR 199.4(g)(39) that 

expressly exclude clinical preventive 

services for TRICARE Standard 

beneficiaries. The prior notice also 

explained the enrollment process and 

cap on DM costs. 

B. Description of Expansion of 

Demonstration Project 

Under this demonstration, DoD has 

waived, for disease management 

services provided to TRICARE Standard 

beneficiaries, the provisions of 10 U.S.C. 

1079(a)(13) and 32 CFR 199.4(g)(39) that 

expressly exclude clinical preventive 

services for TRICARE Standard 

beneficiaries in the current benefit. The 

Military Health System (MHS) has 

enrolled TRICARE Standard 

beneficiaries in its DM programs. DM 

services provided to Standard 

beneficiaries have included, but have 

not been limited to: Clinical preventive 

examinations, patient education and 

counseling services, and periodic 

screening exams. MHS DM program 

costs have been capped not to exceed 

the amount approved by the contracting 

officer. The DM program costs are total 

costs of DM services provided to both 

Prime and Standard beneficiaries. Only 

those beneficiaries identified by the 

TRICARE Management Activity (TMA) 

for disease management of asthma, 

congestive heart failure, and diabetes 

have been included in the current 

program. TMA is now expanding the 

demonstration by including the 

additional disease states of cancer, 

COPD, and anxiety and depression 

disorders. Beneficiaries identified by 

TMA are included in the DM program 

unless they choose to opt out. This 

action directly reduces variation across 

the system and results in improved 

consistency and quality for beneficiaries 

with targeted chronic illness, regardless 

of TRICARE classification. Furthermore, 

including TRICARE Standard 

beneficiaries in current DM efforts 

informs the MHS about total potential 

savings and return on investment (ROI) 

associated with DM, a stated 

requirement of the John Warner 

National Defense Authorization Act for 

Fiscal Year 2007. Continuing to provide 

the current three, and adding the 

additional three diseases to the systemwide DM program, will improve the 

quality of care of our beneficiaries. By 

educating patients about their disease 

and helping them manage their 

symptoms, many of the complications of 

these diseases can be avoided, possibly 

slowing the progression of their chronic 

disease, thus resulting in significant cost 

savings. 

C. Implementation 

The expansion of the demonstration 

will be effective on April 1, 2009. The 

terms and conditions of the original 

demonstration as provided in the Notice 

in 72 FR 32368–32369 will continue on 

that date. 

D. Evaluation 

An independent evaluation of the 

demonstration will be conducted. The 

evaluation will be designed to use a 

combination of administrative and 

survey measures of health care 

outcomes (clinical, utilization, financial, 

and humanistic measures) to provide 

analyses and comment on meeting its 

goal of providing uniform disease 

management policies and practices 

across the MHS. 

Dated: March 9, 2009. 

Patricia L. Toppings, 

OSD Federal Register Liaison Officer, 

Department of Defense. 

[FR Doc. E9–5626 Filed 3–13–09; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Defense Science Board 

AGENCY: Department of Defense. 

ACTION: Notice of advisory committee 

meetings. 

SUMMARY: The Defense Science Board 

will meet in closed session on May 13– 

14, 2009; at the Pentagon, Arlington, 

VA. The mission of the Defense Science 

Board is to advise the Secretary of 

Defense and the Under Secretary of 

Defense for Acquisition, Technology & 

Logistics on scientific and technical 

matters as they affect the perceived 

needs of the Department of Defense. At 

this meeting, the Board will discuss 

interim finding and recommendations 

resulting from ongoing Task Force 

activities. The Board will also discuss 

plans for future consideration of 

scientific and technical aspects of 

specific strategies, tactics, and policies 

as they may affect the U. S. national 

defense posture and homeland security. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Debra Rose, Executive Officer, Defense 

Science Board, 3140 Defense Pentagon, 

Room 3B888A, Washington, DC 20301– 

3140, via e-mail at debra.rose@osd.mil, 

or via phone at (703) 571–0084. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10(d) of the 

Federal Advisory Committee Act, Public 

Law No. 92–463, as amended (5 U.S.C. 

App. 2) and 41 CFR 102–3.155, the 

Department of Defense has determined 

that these Defense Science Board 

Quarterly meeting will be closed to the 

public. Specifically, the Under Secretary 

of Defense (Acquisition, Technology 

and Logistics), with the coordination of 

the DoD Office of General Counsel, has 

determined in writing that all sessions 

of these meetings will be closed to the 

public because they will be concerned 

throughout with matters listed in 5 

U.S.C. 552b(c)(1). 

Interested persons may submit a 

written statement for consideration by 

the Defense Science Board. Individuals 

submitting a written statement must 

submit their statement to the Designated 

Federal Official at the address detailed